Novel high-performance liquid chromatography–tandem mass spectrometry method for simultaneous quantification of BCR-ABL and Bruton’s tyrosine kinase inhibitors and their three active metabolites in human plasma-Reference-Cited by-同舟云学术

Novel high-performance liquid chromatography–tandem mass spectrometry method for simultaneous quantification of BCR-ABL and Bruton’s tyrosine kinase inhibitors and their three active metabolites in human plasma

Published:2020-01 Issue: Volume:1137 Page:121928
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Mukai Yuji,Yoshida Tatsunari,Kondo Takeshi,Inotsume Nobuo,Toda Takaki

Funder

JSPS KAKENHI

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference44 articles.

1. Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposure;Rowland;Expert Opin. Drug Metab. Toxicol.,2017

2. Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia;Picard;Blood,2007

3. R.A. Larson, B.J. Druker, F. Guilhot, S.G. O'Brien, G.J. Riviere, T. Krahnke, I. Gathmann, Y. Wang, I.S. Group, Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study, Blood, 111 (2008) 4022-4028. https://doi.org/10.1182/blood-2007-10-116475.

4. Correlation between imatinib pharmacokinetics and clinical response in Japanese patients with chronic-phase chronic myeloid leukemia;Takahashi;Clin. Pharmacol. Ther.,2010

5. Imatinib plasma trough levels in chronic myeloid leukaemia: results of a multicentre study CSTI571AIL11TGLIVEC;Koren-Michowitz;Hematol. Oncol.,2012

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromatographic and mass spectrometric analytical strategies for profiling tyrosine kinase inhibitors in biological samples;Microchemical Journal;2024-06

2. Simultaneous Determination of Ibrutinib, Dihydroxydiol Ibrutinib, and Zanubrutinib in Human Plasma by Liquid Chromatography–Mass Spectrometry/Mass Spectrometry;Therapeutic Drug Monitoring;2024-03-21

3. A Validated Assay to Quantify Osimertinib and Its Metabolites, AZ5104 and AZ7550, from Microsampled Dried Blood Spots and Plasma;Therapeutic Drug Monitoring;2024-01-24

4. Pretreatment and analysis techniques development of TKIs in biological samples for pharmacokinetic studies and therapeutic drug monitoring;Journal of Pharmaceutical Analysis;2023-11

5. Validation of an LC-MS/MS assay for rapid and simultaneous quantification of 21 kinase inhibitors in human plasma and serum for therapeutic drug monitoring;Journal of Chromatography B;2023-09